DARA Biosciences, Inc.
(NASDAQ:DARA)|
0.51 -0.01 (-1.92%) Dec 01 - Close |
|
|
|
After-Hours 0.73 +0.22 (43.14%) Mon, 1 Dec 2008 6:50 PM
- Compare DARA with:
- View: Line | Candlestick
Company Profile
DARA Biosciences, Inc.
8601 Six Forks Road
Raleigh, -2 27615
United States - Map
Phone: (919) 872-5578
Website: www.darabiosciences.com
State of incorporation: Delaware
CEO: Dr. John Didsbury, Ph.D.
Employees: 8
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biopharma comp. which develop dipeptidyl peptidase
A pharmaceutical company that acquires promising therapeutic molecules and medical technologies from third parties and advances their clinical development for later sale to pharmaceutical companies.
Recent news for DARA
-
DARA BIOSCIENCES, INC. Financials
EDGAR Online Financials - Nov 20 at 9:04 ET
-
DARA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 14 at 6:05 ET
-
EDGAR Online - Oct 22 at 5:03 ET
-
DARA BioSciences Raises $2,255,000 Through the Sale of Common Stock and Warrants
GlobeNewswire - Oct 21 at 4:58 ET
-
DARA BioSciences Announces Completion of Toxicology Studies for Its PPAR-delta/gamma Agonist, DB959
GlobeNewswire - Oct 02 at 8:18 ET